Samsara BioCapital’s Curis CRIS Stock Holding History

Samsara BioCapital’s Portfolio CRIS Stock Details CRIS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-9,297	Closed	-$390K	–	32
2025 Q1	$390K	Sell	9,297 -614	-6%	-$38K	0.07%	32
2024 Q4	$607K	Buy	+9,911	New	+$850K	0.08%	35

Other funds holding CRIS

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $1.15B AUM 24.81% 1-Year Est. Return

Samsara BioCapital's CRIS Position: Q2 2025 in Review

Samsara BioCapital sold out of Curis (CRIS) in Q2 2025, closing a stake of 9,297 shares — an estimated $390K sold.

Samsara BioCapital first reported a position in CRIS in Q4 2024 and held it in 2 quarters. The position peaked at $607K in Q4 2024. 35 funds tracked by Wall St. Rank hold CRIS as of Q2 2025.

Samsara BioCapital reported no remaining Curis position as of Q2 2025 after selling out during the quarter.
Samsara BioCapital sold 9,297 Curis shares in Q2 2025, an estimated $390K.
Samsara BioCapital first reported a position in Curis in Q4 2024 and held it in 2 quarters.
Samsara BioCapital's Curis position peaked at $607K in Q4 2024.
35 funds tracked by Wall St. Rank held Curis as of Q2 2025.

Based on Samsara BioCapital's 13F filing for Q2 2025, filed 14 Aug 2025.